

Biotest is a world-wide operating specialist in immunology and hematology. Biotest manufactures preparations derived from human blood plasma using state-of-the-art biotechnological processes. The preparations are used as immunotherapeutic agents in cases of antibody deficiency or in autoimmune diseases, in severe bacterial infections, in transplantation medicine and in the treatment of coagulation disorders. Products are selling in 159 countries around the globe.
Plasma is obtained, processed and virus-inactivated in accordance with international standards. These guarantee the excellent quality and safety of Biotest’s preparations. One example to achieve the highest possible safety level is integrated additional steps of control and virus inactivation into the production process of plasma proteins; these steps are far more than the legally required procedures.
Approximately 2,000 employees develop, manufacture and sell medicinal products for the treatment of blood and immune diseases as well as products for the hygiene monitoring of air and work surfaces.
Biotest products meet the highest standards and are sold in markets which have to satisfy the most stringent registration requirements in the world.
Biotest stands for high-quality and safe products as well as for efficient and reliable solutions. Quality referring to plasma proteins means safety, tolerability, and user friendliness.
The Biotest Group is also positioned as a premium supplier in the sector of products for microbiological monitoring of the air and of surfaces. To pharmaceutical companies, it supplies solutions that allow them to more rapidly, more efficiently, and more safely meet the control and documentation requirements of government boards.
Volume supstitutional therapy and critical care:
Coagulation:
Immunoglobulins: